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Introduction:Ultrasound for the brain is a revolutionary therapeutic concept. The first
clinical data indicate that 2–4 weeks of therapy with transcranial pulse stimulation
(TPS) improve functional networks and cognitive performance of Alzheimer’s disease
(AD) patients for up to 3months. No data currently exist on possible benefits concern-
ing brain morphology, namely the cortical atrophy characteristic of AD.
Methods:We performed a pre-/post-therapy analysis of cortical thickness in a group
of N= 17 AD patients.
Results:We found a significant correlation between neuropsychological improvement
and cortical thickness increase in AD-critical brain areas.
Discussion: AD patients who benefit from TPS appear to manifest reduced cortical
atrophywithin the defaultmode network in particular, whosememory-related subsys-
tems are believed to be disrupted in AD. TPSmay therefore hold promise as a new add-
on therapy for AD.
KEYWORDS
Alzheimer’s disease, brain stimulation, cortical atrophy, cortical thickness, default mode network,
ultrasound
1 INTRODUCTION
Ultrasound for the brain is a revolutionary new therapeutic concept.
Transcranial techniques such as high-intensity focused ultrasound are
already in clinical use for non-invasive focal surgery, and clinical fea-
sibility studies exist for blood-brain barrier opening for targeted local
drug applications or local gene therapy.1,4 Very recently, a first clinical
study has presented a third major modality of ultrasound application:
therapeutic brain activation in Alzheimer’s disease (AD).2 This study
applied a novel pulsed ultrasound technique, transcranial pulse stim-
ulation (TPS).3 There were two major outcomes: (1) memory improve-
ments up to 3 months post-stimulation, and (2) neurophysiological
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functional magnetic resonance imaging (fMRI) and electroencephalo-
gram (EEG) evidence for improved brain activity and memory network
connectivity. TPS is particularly promising, because it represents an
add-on therapy that may be applied concurrently with established
therapies and therefore increase patients’ chance of improve-
ment. In pathological brains, in which tissue conductivity can be
profoundly altered, electromagnetic methods of transcranial non-
invasive brain stimulation (such as transcranial magnetic- and direct
current stimulation, TMS and tDCS) are difficult to target.6 In contrast,
ultrasound stimulation can be targeted exactly in such cases, because
ultrasound does not depend on intracerebral conductivities.4 Further
ultrasound stimulation and TPS allow stimulation of deep subcortical
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areas.5 As known from a large body of literature, neuroplastic reha-
bilitation involves not only functional7 but also cortico-morphological
changes, in terms of, for instance, MR-derived cortical thickness or
voxel-based morphometry.8,9 However, currently no human or animal
data exist on whether therapy based on ultrasound brain stimulation
can also lead to morphological (namely, cortical thickness) changes.
Here, we aim to fill this gap. Based on the recent evidence of functional
improvement in AD patients, we investigate a possible effect of ultra-




We analyzed data from the 20 AD patients of our previous TPS study,2
for whom structural MR data (T1-weighted, magnetization-prepared
rapid acquisition with gradient echo [MPRAGE] sequence) were avail-
able. The post-scans of two of the patients, and the pre-scan of one
patient, were not available, leaving a sample size of N = 17 with com-
plete pre–postMR data. The quality of cohort was generally “mild AD,”
with clinical AD classification according to the National Institute on
Aging-Alzheimer’s Association criteria.
The study inclusion/exclusion criteria were rather broad, to reflect
the real out-patients’ situation. Namely, inclusion criteria were: clin-
ically stable patients with probable AD, at least 3 months of sta-
ble antidementia therapy (if any), signed informed consent, age ≥18
years. Exclusion criteria were: noncompliance with the protocol, rel-
evant intracerebral pathology unrelated to the AD (eg, brain tumor),
hemophilia or other blood clotting disorders or thrombosis, corticos-
teroid treatment within the last 6 weeks before first treatment.
The protocol for the study has received prior approval by the appro-
priate institutional review board (MUV1227/2015). Informed consent
was obtained from each patient.
2.2 Procedure
Mostpatients receivedTPS therapy for4weeks (threepatients for only
2weeks, one for 3weeks). Functional andmorphologicalMRdatawere
recorded before and after TPS therapy.
2.2.1 TPS therapy and region of interest selection
Individual regions of interest (ROIs) were defined by a neurologist
(R.B.) to target AD-relevant brain areas, that is, the AD network, con-
sisting of: the classical AD stimulation target dorsolateral prefrontal
cortex, areas of thememory (including defaultmode) and language net-
works. Specifically, ROIs comprised: bilateral frontal cortex (dorsolat-
eral prefrontal cortex and inferior frontal cortex extending to Broca’s
area, ROI volume 136/164 cmş – 2×800 pulses per hemisphere), bilat-
Highlights
∙ Ultrasound for the brain provides revolutionary and effec-
tive therapeutic concepts.
∙ Transcranial pulse stimulation (TPS) can precisely target
cortical and subcortical areas.
∙ TPS has been shown to improve functional networks and
cognitive performance in Alzheimer’s disease (AD)
∙ We report such pre–post TPS changes that are predictive
of cortical thickness increase.
∙ TPSmight reduce cortical atrophywithin AD-critical brain
areas such as the default mode network.
Research in context
1. Systematic review: Our previous study indicates that
therapy with ultrasound brain stimulation improves
functional networks and cognitive performance of
Alzheimer’s disease (AD) patients, long term. These prior
results informed our selection of regions of interest for
the present study. We found no other published clinical
studies on the brain-functional and -morphological corre-
lates of ultrasoundbrain stimulation; thiswas ascertained
by searching PubMed using the terms (“ultrasound” AND
“brain stimulation”) AND (“magnetic resonance” OR
“neuroimaging”) AND (“clinical” OR “Alzheimer’s”).
2. Interpretation: As patients improve cognitively, cortical
thickness—in AD-relevant brain regions—increases. We
demonstrate, for the first time, that therapeutic ultra-
sound may change brain morphology, possibly by reduc-
ing cortical atrophy.
3. Future directions: These and other (preclinical) results
provide ample evidence that ultrasound for the brain is an
effective therapeutic concept for precisely targeted non-
invasive brain stimulation. Ultrasound may therefore act
as an add-on therapy for AD by inducing therapeutically
relevant functional andmorphological changes.
eral lateral parietal cortex (extending to Wernicke’s area, ROI volume
122/147 cmş – 2 × 400 pulses per hemisphere), and extended pre-
cuneus cortex (1bilateral volumewith66/92 cmş –2×600pulses). The
goal was to distribute all pulses within the respective ROIswith a focus
on the cortical tissue. Every ROI was stimulated twice per session.
Standardized target volumes of interest (ellipsoidal ROIs) were
defined for each individual participant based on their structural MRI.
This Individual real-time tracking enabled standardized focal brain
stimulation over the whole study population with adequate move-
ments of the hand piece over the skull.
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A NEUROLITH TPS generator (Storz Medical AG, Tägerwilen,
Switzerland) was used, with single ultrasound pressure pulses: dura-
tion about 3 µs, 0.2 mJ mm−2 energy flux density, pulse repetition
frequency 5 Hz, pulse number per therapeutic session 6000. All reg-
ulations required by the Conformité Européenne (CE) authorities have
been fulfilled for acquisition of the CEmark for TPS.
2.2.2 MRI sequence parameters
A T1-weighted structural image was recorded using a MPRAGE
sequence (TE/TR = 2.7/1800 ms, inversion time = 900 ms, flip
angle= 9◦, resolution 1mm isotropic).
2.2.3 Neuropsychological testing
Neuropsychological evaluation was done with the German version of
the CERAD Plus (Consortium to Establish a Registry for Alzheimer’s
Disease) test battery,10 which included tests for: word fluency (phone-
mic and categorical), naming (Boston Naming Test), encoding, recogni-
tion, and recall of verbal material (Word List), as well as constructional
praxis and constructional recall (Figures Copy and Recall). CERAD raw
scores were used to calculate a corrected total score (CTS) for each
patient. CERADdoes not suffer from repetition effects inmild AD.11,12
2.3 Analyses
2.3.1 Cortical thickness derivation and analysis
We used a surface-based morphometry approach to analyze our
anatomical images, as implemented in FreeSurfer (MassachusettsGen-
eral Hospital, Harvard University, Cambridge, Massachusetts, USA).
This involves a standard pre-processing stream to derive cortical sur-
face models (meshes), followed by a longitudinal processing stream to
produce cortical thickness values at both time points; details of these
procedures can be found elsewhere.13–17
For the group analysis of cortical thickness, a simple two-stage
model was used, which performs a linear fit in each subject indepen-
dently, to reduce the repeatedmeasures to a single slope, and then per-
forms a regular cross-sectional analysis across subjects, to look for a
pre–post effect.15,16
2.3.2 Regions of interest and correlational
approach
Our previous fMRI data showed that the entorhinal, parahippocampal,
lateral parietal (inferior and superior), and precuneus areas responded
most significantly to TPS therapy, in the sense that CTS increase was
predicted by activation and connectivity of these areas.2 Therefore, to
examine the case of morphology, we computed correlations between
pre-to-post changes in CERAD CTS and pre-to-post changes in the
cortical thickness of these areas, as defined in the Desikan-Killiany
atlas.14 Both robust correlations,18 that is, skipped Pearson’s r that
accounts for bivariate outliers, and multiple testing correction19 were
used, ensuring valid inference.20
2.4 Data availability
The datasets generated during and/or analyzed during the current
study are available in the TPS_CorticalThickness_Alzheimers repository,
at osf.io/4gsj5.
3 RESULTS
3.1 No pre-to-post change at group level
While a significant pre-to-post behavioral improvement in CTS score
was observed in this N = 17 subgroup (3.76 ± 5.35, t[16] = 2.89,
P= .01), the pre-to-post group-level difference at thewhole brain level
produced no significant clusters after family-wise error (FWE) correc-
tion for multiple comparisons.
3.2 Memory areas that respond functionally to
TPS also respond morphologically
Focusing on the regions of interest suggested by our previous study,
we found significant correlations between changes (pre-to-post TPS)
in the neuropsychological CTS score and in the cortical thickness of
structures of the AD-critical default mode network, namely of the left
superior parietal lobule (r = 0.70 [0.40 0.85], P = .0017) and left pre-
cuneus (r=0.39 [0.10 0.80],P= .03), with only the left superior parietal
lobule being significant after correcting for multiple testing (Figure 1,
Table 1). Adjusting gray matter thickness for age, the results remain
unchanged (left superior parietal: r = 0.69 [0.40 0.80], P = .0016; and
left precuneus: r= 0.56 [0.19 0.80], P= .0160).
4 DISCUSSION
Our study provides the very first data concerning ultrasound brain
stimulation and brain morphology in humans. Results indicate that
the revolutionary concept of ultrasound as an additional avenue
for neurodegeneration therapy, may modulate cortical thickness
of stimulated brain areas and thereby reduce cortical atrophy in
AD. This was found in a set of regions known to be particu-
larly important for AD patients’ cognitive functioning—the default
mode network. This network is important for cognitive and mem-
ory performance and degenerates very early in the course of
AD. Importantly, a global cortical thickness effect—extending to
brain areas less relevant for AD—was absent. These data confirm






F IGURE 1 Brain–behavior correlations. A, Regions of interest—namely left superior parietal lobule (SPL) and left precuneus—where a
significant correlation (plotted in panel [B]) was observed between pre-to-post change in cortical thickness and in neuropsychological scores
(corrected total score [CTS]). The two regions of interest are highlighted with dotted black contours on lateral andmedial views of the DKT atlas
parcellation; base image from theMindboggle project (www.dataverse.harvard.edu/dataverse/mindboggle101).B, Data points in the scatter plot
represent patients (N= 17; SPL: green triangles; precuneus: purple squares). Data points sharing the same x value are horizontally jittered by up to
0.25 units to aid visualization. Vertical/horizontal dotted gray lines correspond to no pre-to-post change in terms of neuropsychological
score/cortical thickness. “Δ” in the axis labels refers to pre-to-post-TPS change.C, Distribution of neuropsychological (CTS) scores, pre- and
post-TPS. Dots represent individual patients, with gray lines connecting values at pre and at post. Horizontal red lines indicate groupmeans.
*P< .05; **P< .01
expectations7 that therapeutic ultrasound may not only have func-
tional effects—something demonstrated in a large variety of animal
and human studies—but may also reduce atrophy of brain tissue that
is treated with TPS. It is important to note that the principle of
therapeutic neuromodulationwith TPS that we describe here need not
only apply to AD but, plausibly, to all neuropsychiatric diseases for
which neuroplastic reorganization may be helpful. If this is true, then
in the case of AD and its specific neuropathology, our results could be
incipient evidence that TPS also acts by reducing cortical atrophy.
The exact cellular mechanisms behind ultrasound-based stimula-
tion, and the direction of the overall effects, that is, whether they cause
an increase or decrease in excitability at a systems level, is currently
under intense research. Most likely, ultrasound neuromodulation rests
on an initial change of cell membrane permeability.21 This causes a cas-
cade of transmitter, humoral factor, and cell activity changeswith long-
term neuroplastic effects. In our previous clinical AD study with TPS,
the procedure was well tolerated and after treatment, memory per-
formance improved for up to 3 months. These results parallel those of
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TABLE 1 Brain–behavior correlations
ROI Pearson’s r 95%CI for r t df P
Right entorhinal 0.3047 [−0.1999, 0.7024] 1.2391 15 .2304
Left enthorinal 0.0075 [−0.3617, 0.3678] 0.0290 15 .9082
Right inferior parietal 0.4184 [−0.1388, 0.7372] 1.7840 15 .1703
Left inferior parietal 0.3470 [−0.2042, 0.6718] 1.4328 15 .2237
Right parahippocampal 0.3936 [−0.1830, 0.7523] 1.6581 15 .1569
Left parahippocampal 0.3630 [−0.1071, 0.6865] 1.5086 15 .0968
Right precuneus 0.4683 [−0.0865, 0.7828] 2.0526 15 .0768
Left precuneus 0.3941 [0.1008, 0.8466] 1.6607 15 .0301
Right superior parietal 0.0906 [−0.2952, 0.4440] 0.3525 15 .6411
Left superior parietal 0.7018 [0.4020, 0.8567] 3.8156 15 .0017
Notes: Robust Pearson correlations between pre-to-post-TPS change in neuropsychological score (CTS) and pre-to-post-TPS change in cortical thickness of
all the functionally relevant ROIs considered. The P-value in bold (left superior parietal) is significant also after correcting for multiple comparisons using a
projection-type outlier detectionmethod.19
Abbreviations: CI, confidence interval; CTS, corrected total score; ROI, region of interest; TPS, transcranial pulse stimulation.
another brain stimulation study investigating the long-term effects of
TMS as a treatment for AD.22
These are the very first in vivo data on ultrasound related brain-
morphological changes, however several limitations of the study have
to be considered. First, TPS stimulation has not been controlled with
a sham stimulation. Notwithstanding, our previous neuropsychological
and functional data demonstrated that only stimulated brain networks
improved, while non-stimulated networks worsened, in that the corre-
sponding neuropsychological performance deteriorated—according to
the expected course of the disease.2 In addition, the long-term course
of neuropsychological improvements clearly differed from the known
placebo responses.23 This corresponds well to our present finding of
no global cortical thickness effect, but of specific effects in function-
ally relevant areas. Second, with this pilot studyMRdata are only avail-
able for pre-/post-therapy time points spanning 2–4 weeks. Whether
morphological changes may be induced for longer time periods—
comparable to the neuropsychological 3-months-on effects—remains
to be investigated.
In conclusion, available evidence indicates that therapeutic ultra-
sound with TPS may indeed be effective as a new add-on therapy for
AD and possibly for other neurodegenerative diseases. Besides induc-
ing memory improvements, here an associated reduction of cortical
atrophy is suggested. This result remains to be confirmed or refuted in
future clinical trials that can provide higher quality of evidence.
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